Picture of Sanara MedTech logo

SMTI — Sanara MedTech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Sanara Medtech Inc. Announces Exclusive License Agreement For Patented Collagen Peptides

Jan 3 (Reuters) - Sanara Medtech Inc  SMTI.O :
    * SANARA MEDTECH INC. ANNOUNCES EXCLUSIVE LICENSE AGREEMENT
FOR
PATENTED COLLAGEN PEPTIDES
    * FORMED A NEW SUBSIDIARY, SANARA COLLAGEN PEPTIDES, LLC
("SCP"),
AND HAS ISSUED 10% OF SCP'S OUTSTANDING UNITS TO TUFTS
    * SCP HAS EXCLUSIVE RIGHTS TO DEVELOP AND COMMERCIALIZE NEW
PRODUCTS BASED ON LICENSED PATENTS AND PATENTS PENDING

Source text for Eikon:  ID:nGNX54wtjX 
Further company coverage:  SMTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sanara MedTech

See all news